These results suggest that intratumoral BNT162b2 treatment significantly increased the recruitment of immune cells into the tumor mass and enhanced the expression of the MHC molecules on both tumor cells and APCs, which are critical for the tumor antigen presentation and the subsequent anti-tumor immune responses. Here, HLA-C is linked to neoplasm.